CNDP1, CN1, CPGL2
Recombinant Human CNDP1 Protein (rh CNDP1) Ser 28 - His 508 (Accession # AAI17123) was produced in human 293 cells (HEK293) at ACRObiosystems.
rh CNDP1, fused with 6×His tag at the C-terminus, has a calculated MW of 54.7 kDa. The predicted N-terminus is Ser 28. DTT-reduced Protein migrates as 60-66 kDa due to glycosylation.
Less than 1.0 EU per μg of the rh CNDP1 by the LAL method.
>95% as determined by SDS-PAGE.
Lyophilized from 0.22 μm filtered solution in 50 mM Tris, 150 mM NaCl, pH 7.4. Normally Mannitol or Trehalose are added as protectants before lyophilization.
Contact us for customized product format or formulation.
See Certificate of Analysis for details of reconstitution instruction and specific concentration.
Avoid repeated freeze-thaw cycles.
No activity loss was observed after storage at:
In lyophilized state for 1 year (4oC); After reconstitution under sterile conditions for 3 months (-70oC).
Beta-Ala-His dipeptidase is also known as Carnosine dipeptidase 1 (CNDP1), CNDP dipeptidase 1, Glutamate carboxypeptidase-like protein 2, Serum carnosinase, CPGL2, which belongs to the peptidase M20A family. CNDP1 is found in serum and adult nervous central system. CNDP1 preferential hydrolysis of the beta-Ala-|-His dipeptide (carnosine), and also anserine, Xaa-|-His dipeptides and other dipeptides including homocarnosine. The catalytic activity of CNDP1 is inhibited by the metal chelator 1,10-o-phenantrolin and the inhibitory concentration 50% (IC50) is 5 µM.
Please contact us via TechSupport@acrobiosystems.com if you have any question on this product.